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 In the not too distant past the research consensus was that 
Attention Deficit/Hyperactivity Disorder (ADHD) is a 
pathophysiologically homogeneous condition: Localise the site of 
the core brain deficit shared in common by ADHD patients, we 
thought, and we will have solved the riddle of the disorder. A 
number of hypotheses regarding what the core to ADHD might be 
were proposed. Of these, the notion that ADHD is a disorder of 
higher order executive control has carried particular weight. 
Especially influential has been the idea, prefigured in other 
theories but most effectively crystallized by Barkley(1), that 
executive dysfunction in ADHD is mediated by alterations in 
fronto-striatal inhibitory processes. The notion of a common 
core to ADHD has since been superseded by models of 
pathophysiological heterogeneity that postulate multiple causal 
pathways to ADHD each mediated by a different constellation of 
brain dysfunction(2).  In these models inhibitory dysfunction is 
regarded as underpinning just one of a number of dissociable and 
different pathways to disorder. Consistent with this, signs of 
inhibitory deficits on laboratory tasks are found in only a 
minority (albeit a substantial minority) of patients(3).  Even 
within this sub-group, however, evidence of inhibitory 
dysfunction needs to be interpreted cautiously given its 
ambiguity at multiple levels (see table 1).  
There is inevitable ambiguity in the ‘read out’ from 
laboratory-based inhibitory tests as these implicate multiple 
cognitive and motivational processes (i.e., neuropsychological 
ambiguity).  Apparent inhibitory failure may in fact be due to 
(i) deficits in more fundamental cognitive functions(4); (ii) 
inefficient allocation of energetic resources(5) and/or (iii) 
poor task engagement linked to motivational abnormalities(6). 
Experimental designs used to disentangle these confounding 
effects can help to clear up some of this ambiguity. However, in 
addition, definitive evidence of underlying inhibitory 
dysfunction requires a shift from the study of 
behaviour/performance to the study of brain processes. 
Successful behavioural inhibition may in fact mask underlying 
abnormalities within inhibitory brain systems as patients either 
apply additional effort or develop compensatory strategies(7) 
(i.e., neuro-biological ambiguity). However, establishing 
inhibitory dysfunction in experimental brain studies still 
leaves unanswered questions about the causal significance of the 
revealed deficits (i.e., developmental ambiguity). Inhibitory 
dysfunction may be core or it may be a secondary effect of 
earlier neuro-developmental patterns of dysfunction established 
through the shaping of neural processes by changing patterns of 
gene expression and experience. Ultimately, therefore, 
discerning the true significance of neuropsychological measures 
of inhibitory dysfunction and their underlying brain correlates 
requires the study of developmental brain phenotypes in 
longitudinal designs(8). Two papers in this issue illustrate the 
potential value of experimental and developmental neuroscience 
approaches to the study of inhibitory deficits in ADHD.  
Doehnart and colleagues (9) carried out a longitudinal 
study of the electrophysiological markers of attention and 
inhibitory control deficits in ADHD. Their goal was to test the 
hypothesis that ADHD is due to a maturational lag in brain 
development.  The study focused on three ERP components each 
postulated to tap specific anterior and posterior brain 
networks.  At the behavioural level data appeared to support the 
idea of a general developmental lag. However, ERP data 
highlighted how potentially misleading relying solely on 
performance measures can be. ADHD effects may mimic age effects 
at the level of behaviour or performance but these effects may 
be unrelated to patterns of neural activation. In fact, in this 
case, developmental patterns seen for the different ERP 
components were complex and network specific, with evidence of a 
developmental lag for some components but not others. Despite 
obvious ADHD-related abnormalities in the cue P300 (recognised 
as a marker of attention-related activation in posterior 
networks) and the CNV (thought to reflect time estimation and 
working memory with a combination of anterior and posterior 
sources) there was little evidence for a developmental lag.  
Deficits existed but they shared little in common with the 
pattern of brain activity seen in younger control children. They 
also remained relatively fixed over the course of the study.  In 
contrast, there was evidence for a developmental lag in the nogo 
P300, a marker of inhibitory-related brain processes.  For this 
component there was a consistent pattern of deficient activation 
at all time points during a period of general rapid 
developmental change seen across the full sample.  Furthermore 
t-maps for the effects of age and ADHD were strikingly similar 
in terms of the localization of nogo P300 effects. As well as 
providing some of the first direct evidence in favour of the 
developmental lag hypothesis (albeit only for certain 
neuropsychological processes), this study also highlights the 
value of combining a sophisticated analysis of cognitive 
processes which distinguishes between specific stimulus-locked 
ERP components, with longitudinal data to address fundamental 
questions about the pathogenesis of ADHD.  
Groom and colleagues (10), while still focusing on the 
significance of apparent inhibitory deficits in ADHD, adopted a 
cross-sectional approach in which they combined experimental 
methods and brain measurement with a pharmacological probe of 
dopamine function (e.g., methylphenidate) to explore the extent 
to which motivational factors might unpin or at least contribute 
to apparent inhibitory control deficits in ADHD.  The results 
were complicated and nicely illustrated the importance of 
experimental, brain-based approaches to inhibitory deficits.  
Crucially ADHD and controls seemed to perform equally 
efficiently on the task. However, despite this there was 
evidence of altered inhibitory-related brain processes as marked 
by alteration in the P300 and N200 components (although the 
effects for the N200 component did not reach statistical 
significance). The appearance of adequate performance on the 
task masked underlying alterations in inhibitory related 
anterior brain networks.  However, these findings remained 
somewhat ambiguous. Data on localization of ERPs was not 
presented nor were analyses conducted for the individual go and 
the no-go stimulus components.  This meant that it remained 
possible that the alterations in the P300 could be linked to 
deficient posterior attention networks rather than, or in 
addition to, the postulated inhibitory deficits in anterior 
networks. Also the behavioural measure of response inhibition 
may have been somewhat blunted by the need to equalise the 
number of correct and incorrect responses using an adjusting 
procedure. This concern over the sensitivity of the index of 
behavioural inhibition was reinforced by the finding that the 
effects of manipulating motivation and dopamine function (i.e., 
methylphenidate) could be seen on inhibitory-related ERP 
measures but not on performance.  Crucially, there was little 
evidence that ADHD-related alterations in brain function were 
normalised by the use of incentives – N200 and P300 components 
exhibited by both ADHD and controls were equally affected by 
either the addition or subtraction of points. More generally 
this study provided little evidence that participants with ADHD 
were deficient in processing point-based incentives or that 
differences in inhibitory-related brain processes in ADHD were 
caused by such motivational deficit. However, it remains 
possible that while points are clearly motivating to a degree, 
for ADHD patients other incentives may be more powerful and 
their application could differentially reduce the apparent 
inhibitory deficit seen in this and other studies. For instance, 
in the delay aversion hypothesis we argue that escape or 
avoidance of delay is an especially powerful reinforcement for 
patients with ADHD(11).  
These studies using experimental and longitudinal designs 
represent a crucial initial step in the development of a 
thoroughgoing experimental developmental neuroscience of ADHD. 
The ultimate goal of such an enterprise must be to integrate the 
descriptive study of changes in ADHD-altered brain processes 
over time into causal neuro-developmental models of the 
condition. Such models posit alterations in the underlying 
neurobiology of ADHD as mediators between originating causes 
(e.g., genes and environments) and the emergence and persistence 
of the disorder, processes that are themselves potentially 
moderated by environmental factors and effects.  Such a 
developmental framework highlights the significance of 
heterogeneity in neuro-developmental pathways marked by specific 
brain phenotypes – whereby specific groups of patients within 
the broader ADHD group can be identified as being distinctive in 
terms of their longitudinal profile of brain development and the 
emergence or amelioration of particular patterns of deficit. 
This heterogeneity represents a fourth level of ambiguity of 
inhibitory dysfunction in ADHD (i.e., taxonomic ambiguity; see 
table 1).  From this perspective the identification of sub-
groups of patients following different neuro-developmental 
pathways marked by different brain alterations and effects 
represents a central goal of ADHD science.  In order to achieve 
this goal, large scale longitudinal studies of brain structure 
and function in ADHD carried out using experimental designs to 
disentangle confounded processes are required. Advanced 
statistical tools (such as growth mixture modelling or latent 
growth curve analysis) can then be used to identify distinctive 
sub-groups of patients following specific neuro-developmental 
pathways. Ultimately it is hoped that such an approach may 
facilitate the identification of novel treatment targets and 
promote the development of new and more effective treatments for 
ADHD(12).  
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Level of Ambiguity 
 
Cause  
 
Implications  
 
Scientific Response  
Neuropsychological Inhibitory tasks tap multiple 
cognitive processes. 
It is unclear whether ADHD-
control differences reflect -  (i) 
inhibitory dysfunction;  (ii) 
deficits in basic cognitive 
processes; (iii) altered energetic  
processes or (iv) lack of 
motivation and engagement.  
Use experimental 
procedures to disentangle 
these effects to more 
precisely specify the source 
of ADHD –control 
performance differences.  
Neurobiological There may be a disconnect 
between response 
inhibition performance and 
the nature of more 
fundamental alterations in 
brain processes.   
Where ADHD patients perform 
well on inhibitory tasks this may 
be masking alterations in more 
fundamental inhibitory brain 
processes which may be covered 
by the application of greater 
effort or the development of 
compensatory strategies.  
Integrate measures of 
inhibitory brain processes in 
studies of response 
inhibition performance.  
Developmental Cross sectional studies do 
not promote an 
understanding of the full 
causal significance of 
inhibitory deficits in ADHD.  
Inhibitory deficits, even when 
validated through the study of 
brain, may play a secondary role 
in ADHD pathogenesis being a 
later effect of earlier established 
processes.  
Conduct longitudinal studies 
to characterize 
developmental brain 
phenotypes relating 
inhibitory brain processes to 
more general neuro-
developmental pathways.  
Taxonomic ADHD is a heterogeneous 
condition - studying  
developmental brain 
phenotypes by averaging at  
the level of the diagnostic 
group as a whole fails to 
take account of this.    
There are likely to be multiple 
pathways from originating causes 
to disorder affecting different 
sub-groups of patients each 
mediated by different 
developmental brain phenotypes 
some implicating inhibitory 
dysfunction and some not.  
Combine large scale 
longitudinal studies with 
advanced statistical 
approaches such a growth 
mixture modeling to 
decompose the performance 
at the group level into sub-
groups with distinct 
developmental trajectories.  
 
Table 1: The sources, implications and solutions to the multiple levels of ambiguities identified in 
inhibitory dysfunction in ADHD.  
  
